Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-17

FDA Approved: CLORAZEPATE DIPOTASSIUM — Supplemental Application (NORTHSTAR RX LLC)

View source ↗

Summary

FDA approved a supplemental application for clorazepate dipotassium submitted by NorthStar RX LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLORAZEPATE DIPOTASSIUM (Clorazepate dipotassium)

Snippet

SUPPL AP for CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)